Alembic Pharmaceuticals Q1 Results
- BSE: 533573
- NSE: APLLTD
- ISIN: INE901L01018
- Sector: Biotechnology & Drugs
BSE
775.00
4.10 (0.53%)
4.10 (0.53%)Volume1.28 K
Updated: Tue 17 Feb, 2026 | 15:29:24
NSE
777.007.15 (0.93%)
7.15 (0.93%)Volume23.09 K
Updated: Tue 17 Feb, 2026 | 15:44:50
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q1 Results Highlights
Quarter ended Jun 25
Note: Comparison is on QoQ basis
Quarterly - Alembic Pharmaceuticals Q1 Results
*All figures in crores except per share values
| Fiscal Period | Jun 25 | Mar 25 | QoQ Comp | Jun 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 1,503.14 | 1,566.70 | -4.06% | 1,393.94 | 7.83% |
| Depreciation/ Amortization | 73.77 | 68.99 | 6.93% | 69.04 | 6.85% |
| Operating Income | 207.58 | 202.93 | 2.29% | 167.79 | 23.71% |
| Net Income | 154.37 | 156.87 | -1.59% | 134.37 | 14.88% |
| Other Operating Expenses Total | 599.19 | 573.50 | 4.48% | 551.04 | 8.74% |
| Net Income Before Taxes | 190.10 | 191.94 | -0.96% | 157.03 | 21.06% |
| Total Revenue | 1,710.72 | 1,769.63 | -3.33% | 1,561.73 | 9.54% |
| Selling/ General/ Admin Expenses Total | 422.77 | 393.59 | 7.41% | 379.77 | 11.32% |
| Diluted Normalized EPS | 7.85 | 8.05 | -2.41% | 6.84 | 14.82% |